CLOCK and cancer: Promising strategies to modulate clock proteins in patients with cancer consist of small molecules targeting biological clock, and synthetic anticancer chronobiotics directed against mammalian circadian clock components (i.e., CRYs, REV-ERBs, and RORs), as well as casein kinases [55].